FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vilho Myllylä

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Prospective Studies

Anatomy

Autonomic Nervous System

Procedures

Co-author Network

Publications

TOP 3
M Matinolli; Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä; Raija Korpelainen
Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study.
Hanna Ansakorpi; Risto Bloigu; Juha T Korpelainen; Vilho V Myllylä; Kalervo Suominen; Uolevi Tolonen; Jouko I T Isojärvi
Evaluation of Heart Rate Variation Analysis during Rest and Tilting in Patients with Temporal Lobe Epilepsy.
Eija Suorsa; Juha T Korpelainen; Hanna Ansakorpi; Heikki V Huikuri; Ville Suorsa; Vilho V Myllylä; Jouko I T Isojärvi
Heart rate dynamics in temporal lobe epilepsy-A long-term follow-up study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vilho Myllylä (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: M Matinolli; Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä; Raija Korpelainen
Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study.
Acta neurologica Scandinavica 2011;123(3):193-200.
2011: Hanna Ansakorpi; Risto Bloigu; Juha T Korpelainen; Vilho V Myllylä; Kalervo Suominen; Uolevi Tolonen; Jouko I T Isojärvi
Evaluation of Heart Rate Variation Analysis during Rest and Tilting in Patients with Temporal Lobe Epilepsy.
Neurology research international 2011;2011():829365.
2011: Eija Suorsa; Juha T Korpelainen; Hanna Ansakorpi; Heikki V Huikuri; Ville Suorsa; Vilho V Myllylä; Jouko I T Isojärvi
Heart rate dynamics in temporal lobe epilepsy-A long-term follow-up study.
Epilepsy research 2011;93(1):80-3.
2010: Anne Saari; Uolevi Tolonen; Eija Pääkkö; Kalervo Suominen; Jukka Jauhiainen; Kyösti A Sotaniemi; Vilho V Myllylä
Sudomotor dysfunction in patients with optic neuritis.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2010;20(3):199-204.
2009: Maarit Matinolli; Juha T Korpelainen; Raija Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Orthostatic hypotension, balance and falls in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):745-51.
2008: A Saari; Uolevi Tolonen; Eija Pääkkö; Kalervo Suominen; Juhani Pyhtinen; Kyösti A Sotaniemi; J Jauhiainen; Vilho V Myllylä
Sympathetic skin responses in multiple sclerosis.
Acta neurologica Scandinavica 2008;118(4):226-31.
2008: Hinni Papponen; Marja Nissinen; Tuula Kaisto; Vilho V Myllylä; Raili Myllylä; Kalervo Metsikkö
F413C and A531V but not R894X myotonia congenita mutations cause defective endoplasmic reticulum export of the muscle-specific chloride channel CLC-1.
Muscle & nerve 2008;37(3):317-25.
2007: Maarit Matinolli; Juha T Korpelainen; Raija Korpelainen; Kyösti A Sotaniemi; Minna Virranniemi; Vilho V Myllylä
Postural sway and falls in Parkinson's disease: a regression approach.
Movement disorders : official journal of the Movement Disorder Society 2007;22(13):1927-35.
2007: Ville Pursiainen; Tarja Haapaniemi; Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Sweating in Parkinsonian patients with wearing-off.
Movement disorders : official journal of the Movement Disorder Society 2007;22(6):828-32.
2007: Ville Pursiainen; Juha T Korpelainen; Tarja Haapaniemi; Kyösti A Sotaniemi; Vilho V Myllylä
Blood pressure and heart rate in parkinsonian patients with and without wearing-off.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(4):373-8.
2007: Ville Pursiainen; T J Korpelainen; H T Haapaniemi; A K Sotaniemi; Vilho V Myllylä
Selegiline and blood pressure in patients with Parkinson's disease.
Acta neurologica Scandinavica 2007;115(2):104-8.
2006: Vilho V Myllylä; Tarja Haapaniemi; Seppo Kaakkola; E Kinnunen; P Hartikainen; J Nuutinen; A Rissanen; A M Kuopio; T Jolma; O Satomaa; H Heikkinen
Patient satisfaction with switching to Stalevo: an open-label evaluation in PD patients experiencing wearing-off (Simcom Study).
Acta neurologica Scandinavica 2006;114(3):181-6.
2006: Tuomo Erola; Esa Heikkinen; Tarja Haapaniemi; Juho Tuominen; A Juolasmaa; Vilho V Myllylä
Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
Acta neurochirurgica 2006;148(4):389-94.
2006: Eija Ronkainen; Juha T Korpelainen; Esa Heikkinen; Vilho V Myllylä; Heikki V Huikuri; Jouko I T Isojärvi
Cardiac autonomic control in patients with refractory epilepsy before and during vagus nerve stimulation treatment: a one-year follow-up study.
Epilepsia 2006;47(3):556-62.
2005: E Ronkainen; Hanna Ansakorpi; Heikki V Huikuri; Vilho V Myllylä; Jouko I T Isojärvi; Juha T Korpelainen
Suppressed circadian heart rate dynamics in temporal lobe epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2005;76(10):1382-6.
2005: AM Mäkikallio; Timo H Mäkikallio; Juha T Korpelainen; O Vuolteenaho; J M Tapanainen; Kari Ylitalo; Kyösti A Sotaniemi; Heikki V Huikuri; Vilho V Myllylä
Natriuretic peptides and mortality after stroke.
Stroke; a journal of cerebral circulation 2005;36(5):1016-20.
2005: Tuomo Erola; Petri Karinen; Esa Heikkinen; Juho Tuominen; Tarja Haapaniemi; John Koivukangas; Vilho V Myllylä
Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.
Parkinsonism & related disorders 2005;11(2):89-94.
2005: Hinni Papponen; Tuula Kaisto; Vilho V Myllylä; Raili Myllylä; Kalervo Metsikkö
Regulated sarcolemmal localization of the muscle-specific ClC-1 chloride channel.
Experimental neurology 2005;191(1):163-73.
2004: Hanna Ansakorpi; Juha T Korpelainen; Päivikki Tanskanen; Heikki V Huikuri; Antero Koivula; Uolevi Tolonen; Juhani Pyhtinen; Vilho V Myllylä; Jouko I T Isojärvi
Cardiovascular regulation and hippocampal sclerosis.
Epilepsia 2004;45(8):933-9.
2004: A Saari; Uolevi Tolonen; Eija Pääkkö; Kalervo Suominen; Juhani Pyhtinen; Kyösti A Sotaniemi; Vilho V Myllylä
Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2004;115(6):1473-8.
2004: AM Mäkikallio; Timo H Mäkikallio; Juha T Korpelainen; Kyösti A Sotaniemi; Heikki V Huikuri; Vilho V Myllylä
Heart rate dynamics predict poststroke mortality.
Neurology 2004;62(10):1822-6.
2004: Mika Kallio; Kalervo Suominen; Tarja Haapaniemi; Kyösti A Sotaniemi; Vilho V Myllylä; Serguei V Astafiev; Uolevi Tolonen
Nocturnal cardiac autonomic regulation in Parkinson's disease.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2004;14(2):119-24.
2004: Leena Vainionpää; Kirsi Mikkonen; Johanna Rättyä; Mikael Knip; Arto J Pakarinen; Vilho V Myllylä; Jouko I T Isojärvi
Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
Epilepsia 2004;45(3):197-203.
2004: Esa Heikkinen; Tuomo Erola; Juho Tuominen; Antero Juolasmaa; Tarja Haapaniemi; Vilho V Myllylä
[The treatment of Parkinson's disease with electric stimulation].
Duodecim; lääketieteellinen aikakauskirja 2004;120(7):789-96.
2003: Virpi Pylvänen; Mikael Knip; Arto J Pakarinen; Jukka Turkka; Mervi Kotila; Johanna Rättyä; Vilho V Myllylä; Jouko I T Isojärvi
Fasting serum insulin and lipid levels in men with epilepsy.
Neurology 2003;60(4):571-4.
2002: Ville Pursiainen; Tarja Haapaniemi; Juha T Korpelainen; Heikki V Huikuri; Kyösti A Sotaniemi; Vilho V Myllylä
Circadian heart rate variability in Parkinson's disease.
Journal of neurology 2002;249(11):1535-40.
2002: Maria K Viitasalo; Ville Kampman; Kyösti A Sotaniemi; Seppo Leppävuori; Vilho V Myllylä; Juha T Korpelainen
Analysis of sway in Parkinson's disease using a new inclinometry-based method.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):663-9.
2002: C Hedman; T Pohjasvaara; Uolevi Tolonen; A Salmivaara; Vilho V Myllylä
Parasomnias decline during pregnancy.
Acta neurologica Scandinavica 2002;105(3):209-14.
2002: C Hedman; T Pohjasvaara; Uolevi Tolonen; A S Suhonen-Malm; Vilho V Myllylä
Effects of pregnancy on mothers' sleep.
Sleep medicine 2002;3(1):37-42.
2002: Hanna Ansakorpi; Juha T Korpelainen; Heikki V Huikuri; Uolevi Tolonen; Vilho V Myllylä; Jouko I T Isojärvi
Heart rate dynamics in refractory and well controlled temporal lobe epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2002;72(1):26-30.
2001: Johanna Rättyä; Arto J Pakarinen; Mikael Knip; M Repo-Outakoski; Vilho V Myllylä; Jouko I T Isojärvi
Early hormonal changes during valproate or carbamazepine treatment: a 3-month study.
Neurology 2001;57(3):440-4.
2001: Jouko I T Isojärvi; Jukka Turkka; Arto J Pakarinen; Mervi Kotila; Johanna Rättyä; Vilho V Myllylä
Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy.
Epilepsia 2001;42(7):930-4.
2001: Jouko I T Isojärvi; Usko E Huuskonen; Arto J Pakarinen; O Vuolteenaho; Vilho V Myllylä
The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.
Epilepsia 2001;42(6):741-5.
2001: Jouko I T Isojärvi; Erik Taubøll; Juha S Tapanainen; Arto J Pakarinen; TJ Laatikainen; Mikael Knip; Vilho V Myllylä
On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
Epilepsia 2001;42(3):305-10.
2001: Jukka S Moilanen; Jaana M Autere; Vilho V Myllylä; Kari Majamaa
Complex segregation analysis of Parkinson's disease in the Finnish population.
Human genetics 2001;108(3):184-9.
2001: Tarja Haapaniemi; Ville Pursiainen; Juha T Korpelainen; Heikki V Huikuri; Kyösti A Sotaniemi; Vilho V Myllylä
Ambulatory ECG and analysis of heart rate variability in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(3):305-10.
2001: Johanna Rättyä; Jukka Turkka; Arto J Pakarinen; Mikael Knip; Mervi Kotila; Olavi Lukkarinen; Vilho V Myllylä; Jouko I T Isojärvi
Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.
Neurology 2001;56(1):31-6.
2001: Vilho V Myllylä; E R Kultalahti; HM Haapaniemi; M Leinonen
Twelve-month safety of entacapone in patients with Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2001;8(1):53-60.
2001: Tarja Haapaniemi; Aapo Ahonen; Pentti Torniainen; Kyösti A Sotaniemi; Vilho V Myllylä
[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):124-30.
2000: Tarja Haapaniemi; Juha T Korpelainen; Uolevi Tolonen; Kalervo Suominen; Kyösti A Sotaniemi; Vilho V Myllylä
Suppressed sympathetic skin response in Parkinson disease.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2000;10(6):337-42.
2000: ML Kauhanen; Juha T Korpelainen; Pauliina Hiltunen; P Nieminen; Kyösti A Sotaniemi; Vilho V Myllylä
Domains and determinants of quality of life after stroke caused by brain infarction.
Archives of physical medicine and rehabilitation 2000;81(12):1541-6.
2000: Tarja Haapaniemi; MA Kallio; Juha T Korpelainen; Kalervo Suominen; Uolevi Tolonen; Kyösti A Sotaniemi; Vilho V Myllylä
Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.
Journal of neurology 2000;247(11):868-74.
2000: MA Kallio; Tarja Haapaniemi; Jukka Turkka; Kalervo Suominen; Uolevi Tolonen; Kyösti A Sotaniemi; V P Heikkilä; Vilho V Myllylä
Heart rate variability in patients with untreated Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7(6):667-72.
2000: ML Kauhanen; Juha T Korpelainen; Pauliina Hiltunen; R Määttä; H Mononen; E Brusin; Kyösti A Sotaniemi; Vilho V Myllylä
Aphasia, depression, and non-verbal cognitive impairment in ischaemic stroke.
Cerebrovascular diseases (Basel, Switzerland) 2000;10(6):455-61.
2000: Jaana M Autere; Jukka S Moilanen; Vilho V Myllylä; Kari Majamaa
Familial aggregation of Parkinson's disease in a Finnish population.
Journal of neurology, neurosurgery, and psychiatry 2000;69(1):107-9.
2000: Juha T Korpelainen; ML Kauhanen; Uolevi Tolonen; E Brusin; H Mononen; Pauliina Hiltunen; Kyösti A Sotaniemi; Kalervo Suominen; Vilho V Myllylä
Auditory P300 event related potential in minor ischemic stroke.
Acta neurologica Scandinavica 2000;101(3):202-8.
2000: Hanna Ansakorpi; Juha T Korpelainen; Kalervo Suominen; Uolevi Tolonen; Vilho V Myllylä; Jouko I T Isojärvi
Interictal cardiovascular autonomic responses in patients with temporal lobe epilepsy.
Epilepsia 2000;41(1):42-7.
1999: Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Autonomic nervous system disorders in stroke.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1999;9(6):325-33.
1999: ML Kauhanen; Juha T Korpelainen; Pauliina Hiltunen; E Brusin; H Mononen; R Määttä; P Nieminen; Kyösti A Sotaniemi; Vilho V Myllylä
Poststroke depression correlates with cognitive impairment and neurological deficits.
Stroke; a journal of cerebral circulation 1999;30(9):1875-80.
1999: Hinni Papponen; T Toppinen; P Baumann; Vilho V Myllylä; Jaakko Leisti; Helena Kuivaniemi; Gerard Tromp; Raili Myllylä
Founder mutations and the high prevalence of myotonia congenita in northern Finland.
Neurology 1999;53(2):297-302.
1999: Juha T Korpelainen; Kyösti A Sotaniemi; AM Mäkikallio; Heikki V Huikuri; Vilho V Myllylä
Dynamic behavior of heart rate in ischemic stroke.
Stroke; a journal of cerebral circulation 1999;30(5):1008-13.
1999: Leena Vainionpää; Johanna Rättyä; Mikael Knip; Juha S Tapanainen; Arto J Pakarinen; Peter Lanning; Aydin Tekay; Vilho V Myllylä; Jouko I T Isojärvi
Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy.
Annals of neurology 1999;45(4):444-50.
1999: Juha T Korpelainen; P Nieminen; Vilho V Myllylä
Sexual functioning among stroke patients and their spouses.
Stroke; a journal of cerebral circulation 1999;30(4):715-9.
1999: Juha T Korpelainen; Kyösti A Sotaniemi; Uolevi Tolonen; Vilho V Myllylä
[Cerebrovascular disorders and the autonomic nervous system].
Duodecim; lääketieteellinen aikakauskirja 1999;115(18):1979-86.
1998: Juha T Korpelainen; ML Kauhanen; H Kemola; U Malinen; Vilho V Myllylä
Sexual dysfunction in stroke patients.
Acta neurologica Scandinavica 1998;98(6):400-5.
1998: C Warren Olanow; Vilho V Myllylä; Kyösti A Sotaniemi; Jan Petter Larsen; S Pålhagen; H Przuntek; EH Heinonen; O Kilkku; RA Lammintausta; O Mäki-Ikola; UK Rinne
Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis.
Neurology 1998;51(3):825-30.
1998: Juha T Korpelainen; Pauliina Hiltunen; Vilho V Myllylä
Moclobemide-induced hypersexuality in patients with stroke and Parkinson's disease.
Clinical neuropharmacology 1998;21(4):251-4.
1998: E H Heinonen; Vilho V Myllylä
Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.
Drug safety : an international journal of medical toxicology and drug experience 1998;19(1):11-22.
1998: P Baumann; Vilho V Myllylä; Jaakko Leisti
Myotonia congenita in northern Finland: an epidemiological and genetic study.
Journal of medical genetics 1998;35(4):293-6.
1998: Jouko I T Isojärvi; Hanna Ansakorpi; Kalervo Suominen; Uolevi Tolonen; M Repo; Vilho V Myllylä
Interictal cardiovascular autonomic responses in patients with epilepsy.
Epilepsia 1998;39(4):420-6.
1998: Jouko I T Isojärvi; Johanna Rättyä; Vilho V Myllylä; Mikael Knip; Riitta Koivunen; Arto J Pakarinen; Aydin Tekay; Juha S Tapanainen
Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
Annals of neurology 1998;43(4):446-51.
1998: Vilho V Myllylä; H Havanka; L Herrala; P Kangasniemi; I Rautakorpi; Jukka Turkka; H Vapaatalo; O Eskerod
Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study.
Headache 1998;38(3):201-7.
1998: Hannu Kalimo; T Aho; Kaarina Amberla; M Baumann; Riitta Herva; Vesa Juvonen; K Kalimo; H Mononen; Vilho V Myllylä; Minna Pöyhönen; J Rinne; Marja-Liisa Savontaus; P Sonninen; V Sonninen; Seppo Tuisku; Matti Viitanen
[CADASIL disease: a hereditary arterial disease leading to brain infarctions and dementia].
Duodecim; lääketieteellinen aikakauskirja 1998;114(20):2041-51.
1997: Juha T Korpelainen; Kyösti A Sotaniemi; Heikki V Huikuri; Vilho V Myllylä
Circadian rhythm of heart rate variability is reversibly abolished in ischemic stroke.
Stroke; a journal of cerebral circulation 1997;28(11):2150-4.
1997: Jouko I T Isojärvi; Arto J Pakarinen; Vilho V Myllylä
Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy.
Seizure : the journal of the British Epilepsy Association 1997;6(3):207-11.
1997: Vilho V Myllylä; Kyösti A Sotaniemi; P Hakulinen; O Mäki-Ikola; EH Heinonen
Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study.
Acta neurologica Scandinavica 1997;95(4):211-8.
1997: Jukka Turkka; Kalervo Suominen; Uolevi Tolonen; Kyösti A Sotaniemi; Vilho V Myllylä
Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease.
Neurology 1997;48(3):662-7.
1997: C Hedman; Matti Jokelainen; Vilho V Myllylä
[Pregnancy and neurological diseases in women].
Duodecim; lääketieteellinen aikakauskirja 1997;113(5):387-92.
1997: Vilho V Myllylä
[Drug therapy of Parkinson's disease].
Duodecim; lääketieteellinen aikakauskirja 1997;113(18):1827-34.
1996: Vilho V Myllylä; Kyösti A Sotaniemi; O Mäki-Ikola; UK Rinne; EH Heinonen
Role of selegiline in combination therapy of Parkinson's disease.
Neurology 1996;47(6 Suppl 3):S200-9.
1996: Juha T Korpelainen; Heikki V Huikuri; Kyösti A Sotaniemi; Vilho V Myllylä
Abnormal heart rate variability reflecting autonomic dysfunction in brainstem infarction.
Acta neurologica Scandinavica 1996;94(5):337-42.
1996: Jouko I T Isojärvi; TJ Laatikainen; Mikael Knip; A J Pakarinen; Katri S Juntunen; Vilho V Myllylä
Obesity and endocrine disorders in women taking valproate for epilepsy.
Annals of neurology 1996;39(5):579-84.
1996: P Baumann; Pertti Tapio Siira; H Vanharanta; Vilho V Myllylä
Quantification of muscle strength in recessive myotonia congenita.
European neurology 1996;36(5):284-7.
1995: Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Asymmetrical skin temperature in ischemic stroke.
Stroke; a journal of cerebral circulation 1995;26(9):1543-7.
1995: Jouko I T Isojärvi; K E Juhani Airaksinen; J N Mustonen; A J Pakarinen; Arja Rautio; Olavi Pelkonen; Vilho V Myllylä
Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine.
Epilepsia 1995;36(8):810-6.
1995: Jouko I T Isojärvi; TJ Laatikainen; A J Pakarinen; Katri S Juntunen; Vilho V Myllylä
Menstrual disorders in women with epilepsy receiving carbamazepine.
Epilepsia 1995;36(7):676-81.
1995: Jouko I T Isojärvi; M Repo; A J Pakarinen; O Lukkarinen; Vilho V Myllylä
Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy.
Epilepsia 1995;36(4):366-70.
1995: Vilho V Myllylä; EH Heinonen; J A Vuorinen; O Kilkku; Kyösti A Sotaniemi
Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease.
Acta neurologica Scandinavica 1995;91(3):177-82.
1995: Jouko I T Isojärvi; A J Pakarinen; Arja Rautio; Olavi Pelkonen; Vilho V Myllylä
Serum sex hormone levels after replacing carbamazepine with oxcarbazepine.
European journal of clinical pharmacology 1995;47(5):461-4.
1994: Jouko I T Isojärvi; A J Pakarinen; Arja Rautio; Olavi Pelkonen; Vilho V Myllylä
Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.
Epilepsia 1994;35(6):1217-20.
1994: Kari Majamaa; H Portimojärvi; K A Sotaniemi; Vilho V Myllylä
Familial aggregation of cervical artery dissection and cerebral aneurysm.
Stroke; a journal of cerebral circulation 1994;25(8):1704-5.
1994: Juha T Korpelainen; Kyösti A Sotaniemi; Kalervo Suominen; Uolevi Tolonen; Vilho V Myllylä
Cardiovascular autonomic reflexes in brain infarction.
Stroke; a journal of cerebral circulation 1994;25(4):787-92.
1993: Helena Kuivaniemi; Darwin J Prockop; Y Wu; S L Madhatheri; C Kleinert; James Earley; A Jokinen; C Stolle; Kari Majamaa; Vilho V Myllylä
Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients.
Neurology 1993;43(12):2652-8.
1993: Kari Majamaa; Vilho V Myllylä
A disorder of collagen biosynthesis in patients with cerebral artery aneurysm.
Biochimica et biophysica acta 1993;1225(1):48-52.
1993: Jouko I T Isojärvi; TJ Laatikainen; A J Pakarinen; Katri S Juntunen; Vilho V Myllylä
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
The New England journal of medicine 1993;329(19):1383-8.
1993: Juha T Korpelainen; Uolevi Tolonen; Kyösti A Sotaniemi; Vilho V Myllylä
Suppressed sympathetic skin response in brain infarction.
Stroke; a journal of cerebral circulation 1993;24(9):1389-92.
1993: Jouko I T Isojärvi; K E Juhani Airaksinen; M Repo; A J Pakarinen; P Salmela; Vilho V Myllylä
Carbamazepine, serum thyroid hormones and myocardial function in epileptic patients.
Journal of neurology, neurosurgery, and psychiatry 1993;56(6):710-2.
1993: Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Asymmetric sweating in stroke: a prospective quantitative study of patients with hemispheral brain infarction.
Neurology 1993;43(6):1211-4.
1993: Jouko I T Isojärvi; A J Pakarinen; Vilho V Myllylä
Serum lipid levels during carbamazepine medication. A prospective study.
Archives of neurology 1993;50(6):590-3.
1993: Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Ipsilateral hypohidrosis in brain stem infarction.
Stroke; a journal of cerebral circulation 1993;24(1):100-4.
1993: Vilho V Myllylä; Kyösti A Sotaniemi; J A Vuorinen; EH Heinonen
Selegiline in de novo parkinsonian patients: the Finnish study.
Movement disorders : official journal of the Movement Disorder Society 1993;8 Suppl 1():S41-4.
1993: Vilho V Myllylä; K A Sotaniemi; A Illi; Kalervo Suominen; T Keränen
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease.
European journal of clinical pharmacology 1993;45(5):419-23.
1992: Juha T Korpelainen; Kyösti A Sotaniemi; Vilho V Myllylä
Hyperhidrosis as a reflection of autonomic failure in patients with acute hemispheral brain infarction. An evaporimetric study.
Stroke; a journal of cerebral circulation 1992;23(9):1271-5.
1992: Kari Majamaa; E R Savolainen; Vilho V Myllylä
Synthesis of structurally unstable type III procollagen in patients with cerebral artery aneurysm.
Biochimica et biophysica acta 1992;1138(3):191-6.
1992: Vilho V Myllylä; Kyösti A Sotaniemi; J A Vuorinen; EH Heinonen
Selegiline as initial treatment in de novo parkinsonian patients.
Neurology 1992;42(2):339-43.
1992: Jouko I T Isojärvi; A J Pakarinen; Vilho V Myllylä
Thyroid function with antiepileptic drugs.
Epilepsia 1992;33(1):142-8.
1991: K A Sotaniemi; M Rantala; Juhani Pyhtinen; Vilho V Myllylä
Clinical and CT correlates in the diagnosis of intracranial tumours.
Journal of neurology, neurosurgery, and psychiatry 1991;54(7):645-7.
1991: Jouko I T Isojärvi; A J Pakarinen; Vilho V Myllylä
A prospective study of serum sex hormones during carbamazepine therapy.
Epilepsy research 1991;9(2):139-44.
1991: Vilho V Myllylä; Kyösti A Sotaniemi; J A Vuorinen; EH Heinonen
Selegiline as a primary treatment of Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1991;136():70-2.
1990: Kyösti A Sotaniemi; Juhani Pyhtinen; Vilho V Myllylä
Correlation of clinical and computed tomographic findings in stroke patients.
Stroke; a journal of cerebral circulation 1990;21(11):1562-6.
1990: Jouko I T Isojärvi; A J Pakarinen; P J Ylipalosaari; Vilho V Myllylä
Serum hormones in male epileptic patients receiving anticonvulsant medication.
Archives of neurology 1990;47(6):670-6.
1989: Jouko I T Isojärvi; A J Pakarinen; Vilho V Myllylä
Thyroid function in epileptic patients treated with carbamazepine.
Archives of neurology 1989;46(11):1175-8.
1989: Jouko I T Isojärvi; A J Pakarinen; Vilho V Myllylä
Effects of carbamazepine on the hypothalamic-pituitary-gonadal axis in male patients with epilepsy: a prospective study.
Epilepsia 1989;30(4):446-52.
1989: Vilho V Myllylä; Kyösti A Sotaniemi; J Tuominen; EH Heinonen
Selegiline as primary treatment in early phase Parkinson's disease--an interim report.
Acta neurologica Scandinavica. Supplementum 1989;126():177-82.
1989: Jouko I T Isojärvi; Vilho V Myllylä; A J Pakarinen
Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patients.
Epilepsia 1989;30(1):50-6.
1988: Jouko I T Isojärvi; A J Pakarinen; Vilho V Myllylä
Effects of carbamazepine therapy on serum sex hormone levels in male patients with epilepsy.
Epilepsia 1988;29(6):781-6.
1988: H K Väänänen; T E S Takala; Uolevi Tolonen; J Vuori; Vilho V Myllylä
Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders.
Archives of neurology 1988;45(11):1254-6.
1988: Vilho V Myllylä; Kyösti A Sotaniemi; Juhani Pyhtinen
Significance of cerebral CT in neurological practice.
Acta neurologica Scandinavica 1988;78(3):228-33.
1987: Jukka Turkka; U Tolonen; Vilho V Myllylä
Cardiovascular reflexes in Parkinson's disease.
European neurology 1987;26(2):104-12.
1987: Jukka Turkka; K K Juujärvi; Vilho V Myllylä
Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease.
European neurology 1987;26(1):29-34.
1987: Jukka Turkka; Vilho V Myllylä
Sweating dysfunction in Parkinson's disease.
European neurology 1987;26(1):1-7.
1987: H Havanka-Kannianinen; K Juujärvi; U Tolonen; Vilho V Myllylä
Cardiovascular reflexes and plasma noradrenaline levels in migraine patients before and during nimodipine medication.
Headache 1987;27(1):39-44.
1986: Jukka Turkka; K K Juujärvi; T O Lapinlampi; Vilho V Myllylä
Serum noradrenaline response to standing up in patients with Parkinson's disease.
European neurology 1986;25(5):355-61.
1983: T E Takala; Vilho V Myllylä; A Salminen; Uolevi Tolonen; I E Hassinen; Veikko Vihko
Lysosomal and nonlysosomal hydrolases of skeletal muscle in neuromuscular diseases.
Archives of neurology 1983;40(9):541-4.